Dr. Burzynski, a nationally and internationally recognized physician/investigator, pioneered the use of biologically active peptides for the treatment of cancer.
In 1967, at the age of 24, Dr. Burzynski graduated first in his class of 250 students from the Medical Academy in Lublin, Poland.
It was at this time that he identified naturally occurring human peptides, which were deficient in cancer patients.
He concluded that these peptides played a role in preventing the growth of cancer cells.
In 1968, he earned a PhD degree and became one of the youngest physician/investigators in Poland to hold both a MD and PhD degree.